Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

  1. San Miguel, J.F.
  2. Weisel, K.C.
  3. Song, K.W.
  4. Delforge, M.
  5. Karlin, L.
  6. Goldschmidt, H.
  7. Moreau, P.
  8. Banos, A.
  9. Oriol, A.
  10. Garderet, L.
  11. Cavo, M.
  12. Ivanova, V.
  13. Alegre, A.
  14. Martinez-Lopez, J.
  15. Chen, C.
  16. Renner, C.
  17. Bahlis, N.J.
  18. Yu, X.
  19. Teasdale, T.
  20. Sternas, L.
  21. Jacques, C.
  22. Zaki, M.H.
  23. Dimopoulos, M.A.
Journal:
Haematologica

ISSN: 1592-8721 0390-6078

Year of publication: 2015

Volume: 100

Issue: 10

Pages: 1334-1339

Type: Article

DOI: 10.3324/HAEMATOL.2015.125864 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals